MDVN

Medivation, Inc. News Headlines

$75.01
*  
0.80
1.06%
Get MDVN Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading MDVN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Good News for BMY/AZN on Dapagliflozin - Analyst Blog
7/29/2013 6:29:01 PM - Zacks.com

Arena Pharma, CY Biotech Unite for Belviq - Analyst Blog
7/29/2013 6:25:01 PM - Zacks.com

Will Amgen (AMGN) Beat Earnings? - Analyst Blog
7/29/2013 4:29:47 PM - Zacks.com

Bull Of The Day: Medivation
7/25/2013 5:42:00 PM - Seeking Alpha

Bull of the Day: Medivation (MDVN) - Bull of the Day
7/25/2013 5:34:01 AM - Zacks.com

EMA's COMP Positive on Raptor's Procysbi - Analyst Blog
7/24/2013 5:29:35 PM - Zacks.com

Illumina Earnings Beat Easily, Guides Up - Analyst Blog
7/24/2013 12:48:01 PM - Zacks.com

Santarus Progresses Uceris Study - Analyst Blog
7/23/2013 6:29:00 PM - Zacks.com

Stocks with Upgraded Broker Ratings - Screen of the Week
7/23/2013 12:41:01 PM - Zacks.com

Insmed Prices Public Offering - Analyst Blog
7/22/2013 4:28:58 PM - Zacks.com

Raghuram 'Ram' Selvaraju On The Best Biotech Ideas Of 2013
7/22/2013 8:20:00 AM - Seeking Alpha

Bayer's Xofigo Data Published - Analyst Blog
7/19/2013 4:48:29 PM - Zacks.com

Pipeline Progress at Synergy Pharma - Analyst Blog
7/19/2013 4:45:01 PM - Zacks.com

Astellas Launches Xtandi in the UK - Analyst Blog
7/12/2013 6:05:01 PM - Zacks.com

Medivation bulls are back for more
7/2/2013 6:16:24 AM - optionMONSTER

Patient Enrolled in Medivation Study - Analyst Blog
6/28/2013 11:31:19 AM - Zacks.com

EU Nod for Medivation/Astellas' Xtandi - Analyst Blog
6/27/2013 6:15:01 PM - Zacks.com

Johnson & Johnson Acquires Another Likely Blockbuster
6/25/2013 5:05:00 AM - Seeking Alpha

Medivation's Xtandi Threatened By Johnson & Johnson's New Acquisition
6/19/2013 10:40:00 AM - Seeking Alpha

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

J&J to Buy Aragon for $1 Billion - Analyst Blog
6/18/2013 11:30:40 AM - Zacks.com

Bulls take another dose of Medivation
6/13/2013 1:20:00 PM - optionMONSTER

Astellas, Tecnofarma in Distribution Deal - Analyst Blog
6/6/2013 6:27:40 PM - Zacks.com

Canada Nod for Medivation's Xtandi - Analyst Blog
6/4/2013 11:27:25 AM - Zacks.com

Medivation/Astellas Seek Xtandi Approval in Japan - Analyst Blog
5/29/2013 4:26:52 PM - Zacks.com